ESC 365 - At the heart of ATTR-CM: Redefining first-line therapy in contemporary care

ESC2025 Premium Access

At the heart of ATTR-CM: Redefining first-line therapy in contemporary care

Session: A new chapter in transthyretin amyloid cardiomyopathy (ATTR-CM): what comes next in clinical practice?

Topic: Cardiac Amyloidosis

Speaker: Professor M. Fontana (London, GB)

Sponsored by Alnylam Pharmaceuticals

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Professor Marianna Fontana

University College London, London (United Kingdom of Great Britain & Northern Ireland)

75 presentations

50 followers

4 more presentations in this session

Welcome and introductions

Speaker: Doctor P. Garcia-Pavia (Majadahonda, ES)

Evolving patient profiles in ATTR-CM: Are we ready to rethink management?

Speaker: Doctor P. Garcia-Pavia (Majadahonda, ES)

From evidence to action: translating data into clinical practice

Speaker: Doctor N. Sarswat (Chicago, US)

Panel discussion and audience Q&A

Speaker: Doctor P. Garcia-Pavia (Majadahonda, ES) Professor M. Fontana (London, GB) Doctor N. Sarswat (Chicago, US)

Access the full session

A new chapter in transthyretin amyloid cardiomyopathy (ATTR-CM): what comes next in clinical practice?

Speakers: Professor M. Fontana, Doctor P. Garcia-Pavia, Doctor P. Garcia-Pavia, Doctor N. Sarswat, Doctor P. Garcia-Pavia...

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

bristol-myers-squibb

Explore sponsored resources

novartis

Explore sponsored resources